- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Roche Holding AG (RHO6)
| Open: | 49.957 | Day's Range: | 49.890 - 50.970 | Volume: | 40 |
|---|---|---|---|---|---|
| Previous Close: | 50.130 | 52wk Range: | 29.900 - 51.429 | 1-Yr Rtn: | +66.70% |
Key Statistics for RHO6
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 8.4120 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (CHF) (ttm) | - |
| Est. EPS (CHF) (12/2013) | 7.5040 |
| Est. PEG Ratio | 1.0840 |
| Market Cap (M EUR) | 175,747.03 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 174 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 2.90% |
| Cash Dividend (USD) | 1.6245 |
| Last Dividend | 03/07/2013 |
| 5 Year Dividend Growth | 14.84% |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for RHO6
Company Profile & Key Executives for RHO6
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.
| Franz B HumerChairman | Severin SchwanChief Executive Officer |
| Alan HippeChief Financial Officer | Urs JaisliChief Compliance Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
RHO6 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page